Hôpital Saint Eloi
Hôpital Saint Eloi
Montpellier, France4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pathophysiological Explorations of Red Blood Cells | erythrocyte disorder | Recruiting | Not stated | 2026-09-09 | NCT03541525 | |
| Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-07-17 | NCT02416388 | |
| Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy | pancreatic adenocarcinoma | Not yet recruiting | Not applicable | 2026-04-23 | NCT07547033 | |
| Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. | Advanced Biliary Tract Carcinoma | Active, not recruiting | Phase 2 | 2025-07-23 | NCT03704480 |